Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

I Tabas, KJ Williams, J Borén - Circulation, 2007 - Am Heart Assoc
The key initiating process in atherogenesis is the subendothelial retention of apolipoprotein
B–containing lipoproteins. Local biological responses to these retained lipoproteins …

Diabetic dyslipidaemia: from basic research to clinical practice

MR Taskinen - Diabetologia, 2003 - Springer
The recognition that the increase of plasma triglyceride rich lipoproteins (TRLs) is
associated with multiple alterations of other lipoproteins species that are potentially …

Vascular endothelium in atherosclerosis

AV Sima, CS Stancu, M Simionescu - Cell and tissue research, 2009 - Springer
Their strategic location between blood and tissue and their constitutive properties allow
endothelial cells (EC) to monitor the transport of plasma molecules, by employing …

Current knowledge on the mechanism of atherosclerosis and pro-atherosclerotic properties of oxysterols

A Zmysłowski, A Szterk - Lipids in health and disease, 2017 - Springer
Due to the fact that one of the main causes of worldwide deaths are directly related to
atherosclerosis, scientists are constantly looking for atherosclerotic factors, in an attempt to …

Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase

AD Tselepis, MJ Chapman - Atherosclerosis Supplements, 2002 - Elsevier
It is well established that inflammation is an integral feature of atherosclerosis and of the
cardiovascular diseases which it underlies. Oxidative stress is also recognized as a key …

Phospholipase A2 regulation of lipid droplet formation

C Guijas, JP Rodríguez, JM Rubio, MA Balboa… - … et Biophysica Acta (BBA …, 2014 - Elsevier
The classical regard of lipid droplets as mere static energy-storage organelles has evolved
dramatically. Nowadays these organelles are known to participate in key processes of cell …

Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the …

RS Rosenson, JD Otvos, DS Freedman - The American journal of …, 2002 - Elsevier
Lipoprotein subclass measurements may enhance the prediction of coronary artery disease
(CAD) risk, but clinical application of such information has been hindered by the relatively …

Phospholipase A2 enzymes and the risk of atherosclerosis

RS Rosenson, E Hurt-Camejo - European heart journal, 2012 - academic.oup.com
Certain members of the phospholipase A2 superfamily of enzymes have established causal
involvement in atherosclerosis, thus at least two groups of this family of enzymes have been …

Thematic review series: the immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?

A Chait, CY Han, JF Oram, JW Heinecke - Journal of lipid research, 2005 - ASBMB
In humans, a chronically increased circulating level of C-reactive protein (CRP), a positive
acute-phase reactant, is an independent risk factor for cardiovascular disease. This …

Phospholipase A2 in Vascular Disease

E Hurt-Camejo, G Camejo, H Peilot, K Öörni… - Circulation …, 2001 - Am Heart Assoc
Secretory phospholipase A2 (PLA2) can be proatherogenic both in the circulation and in the
arterial wall. In blood plasma, PLA2 can modify the circulating lipoproteins and so induce …